Form 8-K - Current report:
SEC Accession No. 0001628280-17-011476
Filing Date
2017-11-13
Accepted
2017-11-13 16:27:23
Documents
3
Period of Report
2017-11-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k_programupdatenov2017.htm 8-K 37981
2 EXHIBIT 99.1 pressreleaseprogramupdate.htm EX-99.1 26915
3 miratilogoa06.jpg GRAPHIC 14525
  Complete submission text file 0001628280-17-011476.txt   80725
Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

EIN.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35921 | Film No.: 171196256
SIC: 2834 Pharmaceutical Preparations